Rhenman & Partners Asset Management AB as of June 30, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 108 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 4.1 | $29M | 2.4M | 11.87 | |
| Exelixis (EXEL) | 3.7 | $26M | 1.1M | 24.63 | |
| Novocure Ltd ord (NVCR) | 3.0 | $21M | 1.2M | 17.30 | |
| Alexion Pharmaceuticals | 2.7 | $19M | 154k | 121.67 | |
| Celgene Corporation | 2.6 | $18M | 142k | 129.87 | |
| Gilead Sciences (GILD) | 2.6 | $18M | 257k | 70.78 | |
| Incyte Corporation (INCY) | 2.5 | $18M | 140k | 125.91 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $17M | 189k | 90.82 | |
| Medtronic (MDT) | 2.4 | $17M | 191k | 88.75 | |
| Esperion Therapeutics (ESPR) | 2.4 | $17M | 363k | 46.28 | |
| UnitedHealth (UNH) | 2.4 | $17M | 90k | 185.42 | |
| Nektar Therapeutics | 2.2 | $16M | 795k | 19.55 | |
| Abiomed | 2.2 | $15M | 106k | 143.30 | |
| Pfizer (PFE) | 2.1 | $15M | 430k | 33.59 | |
| Glaukos (GKOS) | 2.1 | $14M | 346k | 41.47 | |
| Neuroderm Ltd F | 2.0 | $14M | 462k | 29.90 | |
| Jazz Pharmaceuticals (JAZZ) | 1.9 | $13M | 85k | 155.50 | |
| Biogen Idec (BIIB) | 1.9 | $13M | 49k | 271.36 | |
| Allergan | 1.8 | $13M | 52k | 243.10 | |
| Eli Lilly & Co. (LLY) | 1.8 | $12M | 150k | 82.30 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $12M | 95k | 128.87 | |
| Zimmer Holdings (ZBH) | 1.7 | $12M | 90k | 128.40 | |
| Nevro (NVRO) | 1.7 | $12M | 155k | 74.43 | |
| Intra Cellular Therapies (ITCI) | 1.5 | $10M | 833k | 12.42 | |
| Express Scripts Holding | 1.4 | $10M | 156k | 63.84 | |
| Abbvie (ABBV) | 1.4 | $9.8M | 135k | 72.51 | |
| Merck & Co (MRK) | 1.3 | $9.0M | 140k | 64.09 | |
| Humana (HUM) | 1.2 | $8.4M | 35k | 240.63 | |
| Hca Holdings (HCA) | 1.2 | $8.3M | 95k | 87.20 | |
| Centene Corporation (CNC) | 1.1 | $8.0M | 100k | 79.88 | |
| Alkermes (ALKS) | 1.1 | $7.8M | 135k | 57.97 | |
| Walgreen Boots Alliance | 1.1 | $7.8M | 100k | 78.31 | |
| Sanofi-Aventis SA (SNY) | 1.1 | $7.7M | 160k | 47.91 | |
| Dex (DXCM) | 1.1 | $7.6M | 104k | 73.15 | |
| Endologix | 1.1 | $7.7M | 1.6M | 4.86 | |
| CIGNA Corporation | 1.1 | $7.5M | 45k | 167.40 | |
| Regeneron Pharmaceuticals (REGN) | 1.1 | $7.4M | 15k | 491.13 | |
| CVS Caremark Corporation (CVS) | 1.0 | $6.8M | 85k | 80.46 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $6.4M | 80k | 79.76 | |
| Adamas Pharmaceuticals | 0.9 | $6.4M | 368k | 17.49 | |
| Bristol Myers Squibb (BMY) | 0.9 | $6.3M | 114k | 55.72 | |
| Livanova Plc Ord (LIVN) | 0.9 | $6.2M | 102k | 61.21 | |
| Portola Pharmaceuticals | 0.9 | $6.2M | 111k | 56.17 | |
| Kite Pharma | 0.9 | $6.2M | 60k | 103.67 | |
| Universal Health Services (UHS) | 0.9 | $6.1M | 50k | 122.08 | |
| Amgen (AMGN) | 0.9 | $6.0M | 35k | 172.23 | |
| Revance Therapeutics | 0.8 | $5.8M | 220k | 26.40 | |
| Aetna | 0.8 | $5.6M | 37k | 151.84 | |
| Dynavax Technologies (DVAX) | 0.8 | $5.7M | 587k | 9.65 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $5.5M | 120k | 46.00 | |
| Xencor (XNCR) | 0.8 | $5.5M | 260k | 21.11 | |
| NxStage Medical | 0.8 | $5.4M | 214k | 25.07 | |
| Fibrogen | 0.7 | $5.0M | 154k | 32.30 | |
| Anthem (ELV) | 0.7 | $5.0M | 27k | 188.11 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $4.8M | 650k | 7.35 | |
| Immunomedics | 0.7 | $4.7M | 530k | 8.83 | |
| Abbott Laboratories (ABT) | 0.7 | $4.6M | 95k | 48.61 | |
| Thermo Fisher Scientific (TMO) | 0.6 | $4.4M | 25k | 174.48 | |
| Cardinal Health (CAH) | 0.6 | $4.3M | 55k | 77.93 | |
| AmerisourceBergen (COR) | 0.6 | $4.3M | 45k | 94.53 | |
| Omnicell (OMCL) | 0.6 | $4.1M | 94k | 43.10 | |
| Aerie Pharmaceuticals | 0.6 | $3.9M | 75k | 52.55 | |
| Sage Therapeutics (SAGE) | 0.6 | $4.0M | 50k | 79.64 | |
| Edwards Lifesciences (EW) | 0.6 | $3.9M | 33k | 118.24 | |
| Epizyme | 0.6 | $3.8M | 252k | 15.10 | |
| Rigel Pharmaceuticals | 0.5 | $3.8M | 1.4M | 2.73 | |
| DaVita (DVA) | 0.5 | $3.6M | 55k | 64.76 | |
| Array BioPharma | 0.5 | $3.6M | 425k | 8.37 | |
| Radius Health | 0.5 | $3.4M | 75k | 45.23 | |
| Hologic (HOLX) | 0.5 | $3.2M | 70k | 45.39 | |
| Keryx Biopharmaceuticals | 0.4 | $3.1M | 425k | 7.23 | |
| Laboratory Corp. of America Holdings | 0.4 | $3.1M | 20k | 154.15 | |
| Macrogenics (MGNX) | 0.4 | $3.1M | 175k | 17.51 | |
| Endo International | 0.4 | $3.1M | 277k | 11.17 | |
| Coherus Biosciences (CHRS) | 0.3 | $2.4M | 169k | 14.35 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $2.2M | 36k | 62.10 | |
| Tetraphase Pharmaceuticals | 0.3 | $2.1M | 300k | 7.13 | |
| Chimerix (CMRX) | 0.3 | $2.2M | 400k | 5.45 | |
| Bioverativ Inc Com equity | 0.3 | $1.9M | 31k | 60.16 | |
| Insulet Corporation (PODD) | 0.3 | $1.8M | 35k | 51.31 | |
| Halozyme Therapeutics (HALO) | 0.2 | $1.5M | 120k | 12.82 | |
| Supernus Pharmaceuticals (SUPN) | 0.2 | $1.3M | 30k | 43.10 | |
| Rite Aid Corporation | 0.1 | $1.0M | 350k | 2.95 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $837k | 30k | 27.90 | |
| STAAR Surgical Company (STAA) | 0.1 | $755k | 70k | 10.79 | |
| Achillion Pharmaceuticals | 0.1 | $762k | 166k | 4.59 | |
| Forward Pharma A/s | 0.1 | $744k | 37k | 20.34 | |
| Regulus Therapeutics | 0.1 | $588k | 594k | 0.99 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $442k | 4.8k | 91.38 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $389k | 4.8k | 80.66 | |
| Wells Fargo & Company (WFC) | 0.1 | $405k | 7.3k | 55.44 | |
| Concert Pharmaceuticals I equity | 0.1 | $420k | 30k | 13.95 | |
| Catabasis Pharmaceuticals | 0.1 | $441k | 311k | 1.42 | |
| Adverum Biotechnologies | 0.1 | $385k | 154k | 2.50 | |
| Microsoft Corporation (MSFT) | 0.1 | $330k | 4.8k | 68.85 | |
| Halliburton Company (HAL) | 0.1 | $330k | 7.7k | 42.76 | |
| Ford Motor Company (F) | 0.1 | $318k | 28k | 11.20 | |
| Intercept Pharmaceuticals In | 0.1 | $364k | 3.0k | 121.01 | |
| Ocular Therapeutix (OCUL) | 0.1 | $371k | 40k | 9.28 | |
| Orexigen Therapeutics | 0.1 | $348k | 120k | 2.90 | |
| International Business Machines (IBM) | 0.0 | $272k | 1.8k | 154.02 | |
| Qualcomm (QCOM) | 0.0 | $296k | 5.4k | 55.14 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $310k | 2.8k | 110.48 | |
| Mirati Therapeutics | 0.0 | $183k | 50k | 3.66 | |
| Tandem Diabetes Care | 0.0 | $187k | 234k | 0.80 | |
| Threshold Pharmaceuticals | 0.0 | $79k | 202k | 0.39 | |
| Ophthotech | 0.0 | $61k | 24k | 2.55 | |
| Anthera Pharmaceuticals (ANTH) | 0.0 | $41k | 25k | 1.64 |